Title of article
Lymph Node Dissection for Differentiated Thyroid Cancer
Author/Authors
Shaha, Ashok R. Memorial Sloan-Kettering Cancer Center - Head and Neck Service - New York, USA , Mizrachi, Aviram Memorial Sloan-Kettering Cancer Center - Head and Neck Service - New York, USA
Pages
6
From page
10
To page
15
Abstract
Lymph node metastases in differentiated thyroid cancer (DTC) have a wide spectrum of clinical significance. Several variables are taken under consideration when trying to decide on the optimal management of patients with DTC. Routine prophylactic central and/or lateral lymph node dissection is not advocated with exception of central neck dissection for locally advanced tumors. When regarding recurrent disease, foundations have been laid for clinicians to make accurate decisions as to when to perform surgery and when to continue maintaining the patient’s disease under observation. These complex decisions are determined based upon multiple factors, not only regarding the patient’s disease but also the patient’s comprehension of the procedure and apprehension levels. Nevertheless if the patient and/or clinician are emotionally keen to surgically remove the disease then the procedure should be considered.
Keywords
neck dissection , lymph node metastases , Thyroid cancer
Journal title
Molecular Imaging and Radionuclide Therapy
Serial Year
2017
Record number
2575686
Link To Document